Fitness7 months ago
Semaglutide Boosts Kidney Outcomes With Obesity and Cardiovascular Disease
HealthDay News — Once-weekly subcutaneous semaglutide shows a benefit for kidney outcomes in people with overweight or obesity and established cardiovascular disease, according to a study...
